| Butalbital-containing agents: should they be banned? No. | |
| | |
MedLine Citation:
|
PMID: 11872186 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Butalbital compounds are of proven efficacy in the treatment of tension headache. Decades of experience have established their value in the treatment of other mild-to-moderate headaches. Untold numbers of people rely on these medications as their drug of choice or use them when vasoconstrictors, opioids, or nonsteroidal anti-inflammatory agents are contraindicated. The medications are cost-effective with only occasional and minor immediate adverse effects. Their overuse may cause the evolution of episodic primary headaches to chronic daily headaches; however, removal of these agents from the market would reduce the chronic daily headache in the general population by a small fraction of 1%. |
| | |
Authors:
|
Seymour Solomon |
Related Documents
:
|
8740746 - Adjunctive dexamethasone therapy for pediatric bacterial meningitis. 14610136 - The prevalence of migraine in neurologists. 18070056 - Clomiphene citrate for treatment refractory chronic cluster headache. 6844176 - The dizzy patient. symptomatic treatment of vertigo. 18159476 - Three generations of experience and thought in microbiology and infection. 9930706 - Transmyocardial laser revascularization with the co2 laser: one year results of a rando... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current pain and headache reports Volume: 6 ISSN: 1531-3433 ISO Abbreviation: Curr Pain Headache Rep Publication Date: 2002 Apr |
Date Detail:
|
Created Date: 2002-03-01 Completed Date: 2002-07-02 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 100970666 Medline TA: Curr Pain Headache Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 147-50 Citation Subset: IM |
Affiliation:
|
Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. sysol@earthlink.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Barbiturates
/
adverse effects,
economics,
therapeutic use* Controlled Clinical Trials as Topic / statistics & numerical data Drug Therapy, Combination Humans Legislation, Drug* Tension-Type Headache / drug therapy, economics |
| Chemical | |
Reg. No./Substance:
|
0/Barbiturates; 77-26-9/butalbital |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Triptans: are they all the same?
Next Document: Should butalbital-containing analgesics be banned? Yes.